Unicycive Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock (Details)

Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended			9 Months Ended
	Mar. 13, 2024	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2025	Sep. 30, 2024	Jun. 11, 2025	Dec. 31, 2024	Dec. 19, 2024	Dec. 18, 2024	Oct. 31, 2024	Jul. 05, 2024	Jul. 31, 2021
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Gross proceed						$ (3,813)
Share issued price per share		$ 1,000			$ 1,000								$ 50
Designated shares		10,000,000			10,000,000			10,000,000
Common stock shares issued		20,850,363			20,850,363			11,384,236
Preferred stock shares issued		0			0			0
Voting share of common stock					one
Divided shares					1,000
Series B-1 Preferred Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Proceed amount	$ 50,000
Purchase price	$ 1,000
Conversion price	$ 1
Series B-1 Preferred Stock [Member] \| Securities Purchase Agreement [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Share issued	50,000
Series B-1 Preferred Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Designated shares		50,000			50,000
Annual rate					8.00%
Annual dividend rate					14.00%
Outstanding common stock percentage		9.99%			9.99%
Series B-2 Preferred Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Conversion price		$ 10			$ 10
Designated shares		50,000			50,000			50,000
Common stock shares issued							300,000		300,300	144,100	43,800
Preferred stock shares issued		0			0			3,000				7,882
Outstanding common stock percentage		9.99%			9.99%
Voting rights of preferred stock					one
Series B Convertible Preferred Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Common stock shares issued												4,211,800
Series B Preferred Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Outstanding common stock percentage		19.90%			19.90%
Series B Certificate of Designation [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Conversion price		$ 1,000			$ 1,000
Private Placement [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Gross proceed	$ 50,000
Common Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Share issued		6,037,120	1,558,878	450,738
Share issued price per share	$ 1,000												$ 49.9
Common Stock [Member] \| Series B Certificate of Designation [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Voting share of common stock					one